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Abstract—The objective of this research is to develop a long-
term risk model for the development of cardiovascular disease
(CVD) because of type-2 diabetes (T2D). We use the support
vector machine (SVM) and the K-nearest neighbours algorithms
on the dataset collected from a longitudinal study called Framing-
ham Heart Study, to develop the prediction models. The dataset
was first balanced by the Synthetic Minority Oversampling
Technique algorithm. The SVM algorithm was then used to train
the model, and after tuning the parameters and training for 1000
times, the average accuracy to correctly predict the prevalence
of CVD due to T2D came out as 96.5% and the average recall
rate was 89.8%. Similarly, we also applied the KNN algorithm
to train the dataset, and the recall rate even reaches 92.9%. The
advantages of our model are: 1) it can predict with high accuracy
both the risk of development of T2D and CVD simultaneously;
2) it can be used without the expensive and tedious oral glucose
tolerance test. The model yielded high-performance results after
training on the Framingham Heart Study dataset.
Index Terms—Disease prediction, diabetes, cardiovascular dis-
ease, SMOTE, SVM, Distance Correlation, Relief.
I. INTRODUCTION
With the improvement of people’s living standards and
a lax attitude towards maintaining a balanced diet as well
as regular exercise, the incidence of type-2 diabetes (T2D)
increased significantly all over the world from the end of the
20th century to the beginning of the 21st century. According
to the San Antonio Heart Study that took place between
1987 and 1996, and in which more than 5,000 patients were
enrolled, the incidence of T2D almost doubled between 7
and 8 years in both Mexican Americans and non-Hispanic
people of white ethnicity [1]. Similarly, in China, the national
survey in 2013 demonstrated that the prevalence of T2D was
10% [2]. Moreover, there has also been an increasing trend
in the incidence of cardiovascular disease (CVD) worldwide
in recent years since CVD is closely related to T2D. A piece
of robust evidence that T2D was markedly associated with
increased all-cause mortality and increased CVD mortality
was demonstrated in [3]. Besides, a homeostasis model as-
sessment of insulin resistance indicates a great relation in the
incidence of CVD with T2D [4]. According to the annual
report of the International Diabetes Federation (IDF), 12%
of the global health expenditure is spent on diabetes and
its complications. To reduce this huge cost, accurate disease
prediction is necessary and an effective prognostic scheme
must be devised which allows potential patients to have earlier
treatments before progressing to more severe diseases.
Although there are many kinds of research related to the
prediction of T2D, little has been done quantitatively to study
the effects of T2D and CVD together. There are numerous
motivation factors to carry out this research. First, disease
prevention is a noble cause; better prediction models help
high-risk patients to have prevention treatments in time and
therefore, not only improve the quality of life but save the
nation from the burden of the associated treatment costs.
Secondly, the development of disease risk prediction models is
rarely validated through datasets that are collected separately
from the ones upon which the models were trained. In this
study, we use two datasets collected in separate, independent
studies. The data from the Framingham Heart Study (FHS) is
used to train and test the model.
Nowadays, there is an increasing trend in the incidence
of T2D [1]. Many medical organisations have been working
hard to find an approach to predict T2D accurately. Several
empirical indicators have been proposed to measure the risk
of developing T2D, which is also called prediabetes. For exam-
ple, the Homeostatic Model Assessment of Insulin Resistance
(HOMA-IR) is an index to quantify insulin resistance [4].
Matsuda index [5] is a measurement of insulin sensitivity.
Traditionally, the standard model to predict T2D is through
the use of the oral glucose tolerance test (OGTT), which is
a blood test in which glucose is given and blood samples
were taken multiple times in two hours to determine how
quickly it is cleared from the blood. However, the OGTT is
time-consuming and expensive. To replace this inconvenient
procedure, many new models have been tested in clinical
trials, including a modified insulin secretion index and a
clinical model developed from the SAHS. Besides, some other
traditional methods to predict T2D were proposed in [6]–[10].
Moreover, researches related to the correlation between T2D
and CVD can be found in [3], [11], [4]. When it comes to
utilising machine learning methods to predict diabetes or other
diseases, different models have been proposed in recent years.
The paper [12] used four separate machine learning algorithms
to predict Diabetic Mellitus among the adult population, and
the decision tree was found to provide higher accuracy. In [13],
different decision tree classifiers are applied and evaluated
based on their true positive rate and precision. In [14], ten
features were selected from the SAHS dataset upon which
SVM was to predict the future development of T2D. Although
the studies produce good results in terms of prediction of
future T2D, they only employ a single dataset and therefore,
the results cannot be generalised for all demographics and
geographical settings. Also, some serious complications such
as the CVD are not discussed. In this paper, we study the
effect of T2D on the development of CVD through machine
learning.
II. METHODOLOGY
Here we briefly introduce the approaches used to develop
the prediction models, including data processing, feature se-
lection, model training, and evaluation. Initially, we examined
the publicly available datasets from four large institutions,
including FHS, Hospital Frankfurt Diabetes Centre, and Na-
tional Institute of Diabetes and Digestive and Kidney Diseases.
Among them, only the FHS dataset includes cardiovascular
records. Therefore, we collected the FHS dataset as a training
and testing set. The FHS dataset had a total of 8,391 subjects
(including 2,133 men and 6,258 women) aged 40–90 years
[15].
A. Data Pre-processing and Feature Selection
All the null and error values in the dataset were first deleted.
To simplify the model construction and training procedure,
the classification was converted into a binary scheme by
assigning a positive label to the samples with both diabetes and
cardiovascular disease, and negative label to other samples.
Moreover, we normalised all the features to have values
between 0 and 1.
The FHS dataset was highly imbalanced with the negative
class being 37:3,801. As it is well known that such a high-class
imbalance leads to biased results, we applied over-sampling
and down-sampling techniques to balance the two classes. For
over-sampling, we used the SMOTE algorithm. For down-
sampling, we randomly removed samples of the majority class.
After sampling the dataset, the class ratio became 200:799 in
the FHS dataset.
Since the tedious OGTT is time-consuming and expensive,
we selected the body mass index (BMI), age, and the fasting
plasma glucose (FPG) as input features to train the SVM and
KNN models.
B. Model Training
To develop the risk models, we used the SVM and KNN
classification algorithms separately on the FHS dataset. In
terms of KNN, it is one of the simplest models to build a
classifier, an object is classified by the labels of K nearest
neighbours [16]. These K neighbours can do a simple majority
vote and decide the category of new data. The model based
on KNN is determined by three basic elements: distance
measurement, K value selection, and classification decision
rules.
The SVM algorithm constructs a hyperplane or set of hyper-
planes in a high dimensional space for classification [17],
[18]. The nearest samples to the hyper-plane are the support
vectors, which influence the position and orientation of hyper-
plane. The distance between a hyper-plane and the support
vectors is known as the functional margin. Intuitively, a good
classification is achieved with the aid of a larger functional
margin, which decreased generalisation error. generalisation
error.
With the adoption of the SVM and KNN algorithm, we used
the FHS dataset to train and test the model. For each of the
1,000 training iterations, the dataset was shuffled and divided
into training and testing set at a ratio of 4:1. In the training
process, we adjusted three major parameters for SVM; kernel
function, C(penalty), and Γ. By using the grid-search method,
the best parameter combination was selected. For the KNN
model, we set parameters including n-neighbours, weights, and
the metric. By evaluating the results of the trained model based
on different parameters, the best parameters were found.
C. Evaluation
After obtaining the developed prediction model, we eval-
uated it from 2 aspects. Specifically, the developed model
predicts whether a person will develop CVD due to T2D
according to the features. The criterion for evaluation in-
cluded accuracy and recall rate (sensitivity). In most disease
prediction problems, the recall rate (sensitivity) is the more
reliable criterion instead of accuracy, due to the unavoidable
imbalanced dataset. Recall rate refers to the true positive rate
(TPR = TP/(TP + FN)), where TP and FN are the true
positives and false negatives respectively.
III. RESULTS AND DISCUSSION
To train and test the model, we chose BMI, age, and
FPG as the input features. Results of the KNN and SVM
model are shown separately. When training the KNN model
for 1,000 times in the FHS dataset, the corresponding
accuracy, and recall rate are shown in Table I. The
accuracy is at 96.9% and the recall rate reaches 92.9%.
The selected parameters combination for the KNN is:
{’n’:5,’weights’:’uniform’,’algorithm’:
’auto’, ’metric’:’minkowski’,’leaf-size’:
30, ’p’:2}. The confusion matrix of the KNN model is
shown in Fig. 1. Because some data were synthesised during
the oversampling procedure, the confidence level in the
sampled datasets decreased, however, the overall performance
remained high.
TABLE I
AVERAGE ACCURACY AND RECALL RATE OBTAINED FROM THE KNN

















Fig. 1. The confusion matrix for the trained KNN model.
When training the SVM model for 1,000 times in the FHS
dataset using the grid-search, the best parameters, the corre-
sponding accuracy, and recall rate are shown in Table II. The
selected best parameters set is: {’C’:100, ’gamma’:20,
’kernel’:’rbf’}. The model performed well with the
average accuracy at 96.5%, and the sensitivity reaching 89.8%,
as shown in Fig. 2. The performance in terms accuracy is less
satisfactory than that of the KNN model, but the results are
also persuasive in this disease prediction problem.
TABLE II
AVERAGE ACCURACY AND RECALL RATE OBTAINED FROM THE SVM





In this paper, we used machine learning to develop a future
cardiovascular disease (CVD) risk prediction model due to
type-2 diabetes (T2D). The support vector machine (SVM) and
K nearest neighbours (KNN) supervised learning algorithms
were used to develop the model for which the Framingham
dataset was utilised for training and testing. A remarkable
aspect of this study is that it only requires anthropometric
measurements and standard blood test recordings but still
yield excellent results. Despite the huge imbalance of both
the datasets, our model had an average accuracy calculated
over 1,000 iterations equal to 96.5% and a recall rate of
89.8% in the FHS dataset based on SVM method, and more
importantly, the recall rate reaches 92.9% when training KNN
in the FHS dataset. In comparison with other risk prediction
models, our model does not require the costly oral glucose
tolerance test. Furthermore, it can simultaneously predict both














Fig. 2. The confusion matrix for the SVM model.
For the future work, we recommend a multi-class classifi-
cation performed on the dataset and evaluating the developed
models on contemporary datasets.
ACKNOWLEDGEMENT
This publication was made possible by NPRP grant number
NPRP 10-1231-160071 from the Qatar National Research
Fund (a member of Qatar Foundation). The statements made
herein are solely the responsibility of the authors.
REFERENCES
[1] J. P. Burke, K. Williams, S. P. Gaskill, H. P. Hazuda, S. M. Haffner,
and M. P. Stern, “Rapid rise in the incidence of type 2 diabetes from
1987 to 1996: results from the San Antonio Heart Study,” Archives of
Internal Medicine, vol. 159, no. 13, pp. 1450–1456, 1999.
[2] C. D. Society, “Guidelines for the prevention and treatment of type 2
diabetes in China (2017 edition),” Chin J Diabetes, vol. 10, no. 1, pp. 4–
67, 2018.
[3] M. Wei, S. P. Gaskill, S. M. Haffner, and M. P. Stern, “Effects of diabetes
and level of glycemia on all-cause and cardiovascular mortality: the San
Antonio Heart Study,” Diabetes care, vol. 21, no. 7, pp. 1167–1172,
1998.
[4] A. J. Hanley, K. Williams, M. P. Stern, and S. M. Haffner, “Homeostasis
model assessment of insulin resistance in relation to the incidence of
cardiovascular disease: the San Antonio Heart Study,” Diabetes care,
vol. 25, no. 7, pp. 1177–1184, 2002.
[5] M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained
from oral glucose tolerance testing: comparison with the euglycemic
insulin clamp,” Diabetes Care, vol. 22, pp. 1462–1470, Sep 1999.
[6] C. Lorenzo, K. Williams, and S. Haffner, “Insulin secretion based on
the late oral glucose tolerance test period and incident diabetes: the San
Antonio Heart Study,” Diabetic Medicine, vol. 29, no. 8, pp. e151–e158,
2012.
[7] M. P. Stern, K. Williams, and S. M. Haffner, “Identification of persons
at high risk for type 2 diabetes mellitus: do we need the oral glucose
tolerance test?,” Annals of internal medicine, vol. 136, no. 8, pp. 575–
581, 2002.
[8] M. A. Abdul-Ghani, T. Abdul-Ghani, M. P. Stern, J. Karavic, T. Tuomi,
I. Bo, R. A. DeFronzo, and L. Groop, “Two-step approach for the
prediction of future type 2 diabetes risk,” Diabetes Care, vol. 34, no. 9,
pp. 2108–2112, 2011.
[9] M. A. Abdul-Ghani, K. Williams, R. A. DeFronzo, and M. Stern, “What
is the best predictor of future type 2 diabetes?,” Diabetes care, vol. 30,
no. 6, pp. 1544–1548, 2007.
[10] K. Chien, T. Cai, H. Hsu, T. Su, W. Chang, M. Chen, Y. Lee, and F. Hu,
“A prediction model for type 2 diabetes risk among Chinese people,”
Diabetologia, vol. 52, no. 3, p. 443, 2009.
[11] C. Lorenzo, K. Williams, K. J. Hunt, and S. M. Haffner, “Trend in the
prevalence of the metabolic syndrome and its impact on cardiovascular
disease incidence: the San Antonio Heart Study,” Diabetes care, vol. 29,
no. 3, pp. 625–630, 2006.
[12] M. F. Faruque, I. H. Sarker, et al., “Performance analysis of machine
learning techniques to predict diabetes mellitus,” in 2019 International
Conference on Electrical, Computer and Communication Engineering
(ECCE), pp. 1–4, IEEE, 2019.
[13] D. Vigneswari, N. K. Kumar, V. G. Raj, A. Gugan, and S. Vikash,
“Machine learning tree classifiers in predicting diabetes mellitus,” in
2019 5th International Conference on Advanced Computing & Commu-
nication Systems (ICACCS), pp. 84–87, IEEE, 2019.
[14] H. Abbas, L. Alic, M. Rios, M. Abdul-Ghani, and K. Qaraqe, “Predicting
diabetes in healthy population through machine learning,” in 2019 IEEE
32nd International Symposium on Computer-Based Medical Systems
(CBMS), pp. 567–570, IEEE, 2019.
[15] B. Wang, M.-C. Liu, X.-Y. Li, X.-H. Liu, Q.-X. Feng, L. Lu, Z. Zhu, Y.-
S. Liu, W. Zhao, and Z.-N. Gao, “Cutoff point of HbA1c for diagnosis
of diabetes mellitus in Chinese individuals,” PLOS One, vol. 11, no. 11,
p. e0166597, 2016.
[16] Tavish Srivastava, “Introduction to k-nearest neighbors: A powerful
machine learning algorithm,” 2018. [Online; accessed 28-August-2019].
[17] C. Cortes and V. Vapnik, “Support vector networks,” Machine Learning,
vol. 20, pp. 273–297, 1995.
[18] V. N. Vapnik and A. Y. Chervonenkis, “On the uniform convergence
of relative frequencies of events to their probabilities,” in Measures of
complexity, pp. 11–30, Springer, 2015.
